Atlas Trials

Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects

Clinical trial NCT01802073 · COMPLETED

Trial details

NCT number
NCT01802073
Sponsor
Stanford University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Sclerosing Cholangitis
Start date
2012-01-01
Primary completion
2015-08-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.